Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?
- 1 January 2001
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 87 (1), 31-34
- https://doi.org/10.1046/j.1464-410x.2001.00984.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic ObstructionEuropean Urology, 1999
- Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive menBJU International, 1998
- Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safetyProstate Cancer and Prostatic Diseases, 1998
- Clinical comparison of selective and non‐selective &agr;1A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing dosesBJU International, 1997
- Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)BJU International, 1997
- The International Terazosin Trial: A Multicentre Study of the Long-Term Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1996
- Doxazos1n in physiologically and pharmacologically normotensive men with benign prostat1c hyperplasiaUrology, 1995
- Doxazosin in benign prostatic hyperplasia: Effects on blood pressure and urinary flow in normotensive and hypertensive menUrology, 1995
- Effect of dosing regimen on efficacy and safety of doxazosin in normotensive men with symptomatic prostatism: A pilot studyUrology, 1994
- Safety assessment of terazosin in thetreatment of patients with symptomatic benign prostatic hyperplasia: A combined analysisUrology, 1994